Financing Buprenorphine in the Treatment of Opioid Addiction

More documents

Recommendations

Info

• AvisaGroup Buprenorphine is the opiate dependence medication most often reportedly “covered” by Medicaid Survey Findings (2008) Coverage Number States Offer Medicaid coverage of methadone in NTPs Offer Medicaid coverage of buprenorphine in physicians’ offices Offer Medicaid coverage of buprenorphine in NTPs Offer Medicaid coverage of naltrexone in physicians’ offices Offer Medicaid coverage of naltrexone in NTPs 34 38 30 31 19 TRI science addiction
• • More AvisaGroup SAPT Block Grant funds rarely used to cover medication-assisted opioid treatment, except in some cases where states supplement MAT funding in NTP’s Survey Findings Coverage Number States SAPT Block Grant Funding for buprenorphine in physicians’ offices SAPT Block Grant Funding for buprenorphine in NTPs SAPT Block Grant Funding for naltrexone in physicians’ offices SAPT Block Grant Funding for naltrexone in NTPs 2 12 2 7 TRI science addiction
Page 1 and 2: Financing Buprenorphine in the Trea
Page 3 and 4: • • Introduction Treatment orga
Page 5 and 6: • • Context In the public secto
Page 7 and 8: • • Private Sector Issues Given
Page 9: • • • Pricing Pricing of medi
Page 14 and 15: • • Conclusions We need to bett
Page 16: Contact Information Mady Chalk, Ph.

Financing Buprenorphine in the Treatment of Opioid Addiction

Create successful ePaper yourself

Delete template?

Save as template?